Edition:
United Kingdom

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

12.10USD
19 Jun 2018
Change (% chg)

$-0.25 (-2.02%)
Prev Close
$12.35
Open
$12.15
Day's High
$12.20
Day's Low
$11.88
Volume
177,667
Avg. Vol
199,461
52-wk High
$14.73
52-wk Low
$2.58

Chart for

About

Vericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through... (more)

Overall

Beta: 3.12
Market Cap(Mil.): $160.84
Shares Outstanding(Mil.): 32.82
Dividend: --
Yield (%): --

Financials

  VCEL.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -1.09 -- --
ROI: -120.46 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Vericel Q4 Revenue Rose 41 Pct To $23.4 Mln

* VERICEL REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2018 FINANCIAL GUIDANCE

05 Mar 2018

BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics   

* VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​

02 Jan 2018

Earnings vs. Estimates